The Henry M. Jackson Foundation for the Advancement of Military Medicine is a private, not-for-profit organization established in 1983 and authorized by Congress to support medical research and education at the Uniformed Services University of the Health science and throughout the military medical community. The Foundation was named in honor of Washington State Senator Henry "Scoop" Jackson, who sponsored the original legislation. Senator Jackson had a long-standing commitment to military medicine and health.HJF provides scientific and management services, from infrastructure development, financial administration and clinical trials management to staffing, continuing medical education and event planning. The Foundation works with a variety of programs, from large multi-site trials to small, benchtop projects, both nationally and abroad. USU, located in Bethesda, Maryland, is the nation’s only federal school of medicine and graduate school of nursing. It was established by Congress in 1972. The University’s curriculum is similar to that of its civilian counterparts, but it also provides additional specialized education elements geared towards producing career uniformed officers. USU was a major focus of the documentary film Fighting for Life, which was released in 2008.HJF’s largest program is the U.S. Military HIV Research Program , whose mission is to protect U.S. military personnel and aid the international fight against HIV. Established in 1988, the program focuses on HIV vaccine development, prevention, disease surveillance and care and treatment for HIV.The Foundation supports more than 1,000 additional research projects at USU and throughout military medicine, including the Center for Prostate Disease Research, the Navy Biological Defense Directorate, the Center for the Study of Traumatic Stress and the Center for Disaster and Humanitarian Assistance Medicine. It employs more than 2,400 scientific, medical, management and administrative personnel. HJF also manages endowments for USU and promotes government-civilian partnerships through its Center for Public-Private Partnerships Wikipedia.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc | Date: 2014-02-28
The present invention relates to oncogenes or tumor suppressor genes, as well as other genes, involved in prostate cancer and their expression products, as well as derivatives and analogs thereof. Provided are therapeutic compositions and methods of detecting and treating cancer, including prostate and other related cancers. Also provided are methods of diagnosing and/or prognosing prostate cancer by determining the expression level of at least one prostate cancer-cell-specific gene, including, for example, the ERG gene or the LTF gene alone, or in combination with at least one of the AMACR gene and the DD3 gene.
Meso Scale Technologies LLC and Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc | Date: 2015-09-15
The present invention relates to methods and kits to assess an absorbed dose of ionizing radiation and/or the severity of tissue injury from radiation in a patient. The invention also relates to algorithms used to calculate an absorbed dose of radiation based on biomarker measurements of a plurality of biomarkers that are altered relative to a normal control in the event of radiation exposure.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc and The Government Of The United States Of America | Date: 2014-09-18
The present invention relates to monoclonal antibodies that bind or neutralize Hendra or Nipah virus. The invention provides such antibodies, fragments of such antibodies retaining Hendra or Nipah virus-binding ability, fully human antibodies retaining Hendra or Nipah virus-binding ability, and pharmaceutical compositions including such antibodies. The invention further provides for isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith. Additionally, the invention provides for prophylactic, therapeutic, and diagnostic methods employing the antibodies and nucleic acids of the invention.
Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc | Date: 2015-04-30
This invention relates to soluble forms of G glycoprotein from Hendra and Nipah virus. In particular, this invention relates to compositions comprising soluble forms of G glycoprotein from Hendra and Nipah virus and also to diagnostic and therapeutic methods using the soluble forms of G glycoprotein from Hendra and Nipah virus. Further, the invention relates to therapeutic antibodies including neutralizing antibodies, and vaccines for the prevention and treatment of infection by Hendra and Nipah viruses.
Virginia Commonwealth University and Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc | Date: 2014-07-29
The invention generally relates to dextran fibers which are preferably electrospun and devices formed from such fibers. In particular, such devices may include substances of interest (such as therapeutic substances) associated with the electrospun fibers. Upon exposure to a liquid the electrospun fibers dissolve immediately and the substances of interest are released into the liquid. Exemplary devices include bandages formed from electrospun dextran fibers and associated agents that promote hemostasis, such as thrombin and fibrinogen.